Metraipolis › archive › dc_dbbc7e0f5e76

Efficacy and safety of radiotherapy combined with immunotherapy and targeted therapy versus immunotherapy plus targeted therapy alone in unresectable… — Europe PMC PMID:40909949

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40909949
DOI
10.3389/fonc.2025.1643304
License (as archived)
solo-consultazione
Archived
2026-11-10T11:47:01.821Z
SHA-256 of the archived text
6a40fa8415567220975e5ad4657d9c8474cb55396a894ca1cd5a14e8d7e6e314
Stable URL of this page
https://metraipolis.com/documento/dc_dbbc7e0f5e76

How to cite

Efficacy and safety of radiotherapy combined with immunotherapy and targeted therapy versus immunotherapy plus targeted therapy alone in unresectable… — Europe PMC PMID:40909949 — Europe PMC (en), https://europepmc.org/article/MED/40909949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbbc7e0f5e76 (Metraipolis archive dc_dbbc7e0f5e76, sha256 6a40fa8415567220975e5ad4657d9c8474cb55396a894ca1cd5a14e8d7e6e314)
BibTeX
@misc{dcdbbc7e0f5e76,
  title = {Efficacy and safety of radiotherapy combined with immunotherapy and targeted therapy versus immunotherapy plus targeted therapy alone in unresectable… — Europe PMC PMID:40909949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40909949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbbc7e0f5e76; sha256 6a40fa8415567220975e5ad4657d9c8474cb55396a894ca1cd5a14e8d7e6e314},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40909949. Agents can read the archived copy with the MCP tool read_document.